Anti-Asthma Drugs Market Information, by Type of Asthma (Allergic (Extrinsic) and Non-Allergic (Intrinsic) Asthma), by Asthma Trigger Type (Child-Onset Asthma, Adult-Onset Asthma, Exercise-Induced Asthma, Cough-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma (Severe Asthma)), by Drug Class (Bronchodilators (Beta Agonists, Anti-Cholinergics, Xanthines), Leukotriene Antagonists, Mast Cell Stabilizers, Corticosteroids, Monoclonal Antibody), by Therapy (Reliever Treatment and Maintenance Treatment) and by Route of Administration (Oral, Inhaled, Intravenous, Subcutaneous)- Global Forecast to 2022Anti-Asthma Drugs Market - Overview With the air pollution rising around the world, the number of asthma patients is also increasing.
Market Research Future (MRFR) has published a research report that envisions surge in the global Anti-Asthma Drugs market with 5.94% CAGR (Compound Annual Growth Rate) between 2015 and 2022.
It also follows the competitive developments such as joint ventures, new product developments, mergers and acquisitions, new product developments (R & D) in the market.According to this report, the key factors that drive this growth of this market include growing awareness of the benefits of modern drug therapy, the great potential of biologics, growth in patients due to increasing pollution, and problems arising from consumerism & unhealthy lifestyles.
Constraints that can make the market growth hit a roadblock are the fear among leading drug brands regarding the loss of patents of leading brands and increasing fragmentation of markets and generic penetration.Anti-Asthma Drugs Market - SegmentationThe Global Anti-Asthma Drugs Market has been segmented on the basis of drug class, route of administration, therapy, trigger, type, and lastly, region.
23 June 2018Morepen Laboratories Ltd. has received approval from the United States Food and Drug Administration (USFDA) for both its bulk drugs manufacturing facilities situated in Himachal Pradesh, India.
30 Jul 2018Anti-Asthma Drugs Market - Regional AnalysisThe regional segmentation of the global anti-asthma drugs market segments the market into regional markets namely The Americas (North America & South America), Europe, Asia Pacific, the Middle East & Africa (MEA).